Veterinary pain management market is expected to register a CAGR of 6.46% during the assessment period, to reach USD 4.5 Billion by 2027
Veterinary pain management market is expected to register a CAGR of 6.46% during the assessment period (2020 to 2027), to reach USD 4.5 Billion by 2027. The number of suppliers and manufacturers of pain relief products and equipment around the world is growing, providing tremendous growth prospects for both existing companies and new entrants.
The Global Economy can be impacted by COVID-19 in three main ways: by directly influencing production and consumption, by creating a supply chain and disrupting manufacturing, and by its strategic effect on companies and financial markets.
Veterinary Pain Management Market Dynamics
Growing Animal Welfare Funding to Drive Market Growth
The growth of the global veterinary pain management industry is projected to be influenced by the rise in companion animal ownership and large livestock population, the rise in pet insurance with an increase in animal welfare spending, and the rising prevalence of animal diseases. Moreover, the growth of the industry is motivated by a rise in the need to sustain animal health and safety in developed countries and by an increase in the acceptance of pet insurance worldwide. Furthermore, the rise in the incidence of animal diseases causing pain and inflammation is driving the development of the industry. Over the prognosis period, the growing number of pet owners worldwide is expected to help business growth.
Growing Exploration of Untapped Markets to Create Growth Avenues for the Key Players
In comparison, the rise in prevalence of non-conventional and non-pharmaceutical treatment methods and untapped emerging markets is projected to provide the industry with future growth opportunities.
Lack of Information Impedes Market Growth
The lack of knowledge of severe disease problems in service animals, however, limits the development of the market.
Veterinary Pain Management Market Segmental Analysis
Veterinary pain management market is Segmented Based on Animal Type, Product, Application, and Distribution Channel.
The Veterinary Pain Management Market, on the basis of product, has been divided into medications, and devices. In 2019, the drug group accounted for the greatest market share. The fact that veterinary medicine is more affordable, easier to prescribe and to treat a larger variety of diseases that cause discomfort in both farm and pet animals is largely due to the vast share of this commodity market.
The demand for veterinary pain drugs has been further segmented into oral, parenteral, and topical, depending on the route of administration. The market share for the oral route of administration is influenced by the increasing preference for oral treatment and medications.
The Veterinary Pain Management Market, based on animal type, has been bifurcated into companion animals and livestock animals. In 2019, the growing occurrence rate of zoonotic diseases, high expenditure on animal welfare, and increasing pet insurance are significant drivers for the growth of the companion animal market.
By use, the Global Veterinary Pain Relief Market has been divided into joint pain, postoperative pain, cancer, and others. The joint pain segment held the biggest market share in 2019. During the projected era, a high osteoarthritis population and new product releases are expected to fuel demand growth.
The Global Veterinary Pain Relief Market has been segmented into veterinary hospitals & clinics, dispensaries, and online pharmacy by delivery channel. Thanks to the large supply of pain drugs in these settings, veterinary hospitals and clinics held the biggest share in 2019.
Veterinary Pain Management Market Regional Analysis
The geographical overview of the Veterinary pain management market has been conducted in four major regions, including the Asia Pacific, North America, Europe, and the Middle East and Africa.
North America leads the Americas with established end-use Sectors
The Americas has been divided into North America and Latin America, with the US and Canada more divided into the North American market. In 2019, the Americas had the highest market share for the treatment of veterinary pain. This proportion is due to the growing population of dogs, the introduction of new drugs and the rising number of neurological diseases in the area. The US is projected to have the largest share of the global market in North America due to the massive pet population in the country, increased spending on animal welfare, a large number of hospitals & clinics, a rising pool of veterinarians, and the high prevalence of pain-causing diseases, as well as the increasing number of research and funding initiatives in the field of veterinary pain management.
Germany to Lead Europe Market
Western Europe and Eastern Europe have been split into the European veterinary pain relief market. Furthermore, the Western European market for veterinary pain relief has been divided into Germany, France, the UK, Italy, Spain and the rest of Western Europe. In the worldwide veterinary pain relief industry, Europe accounts for the second largest share. In European countries, the high prevalence of cancer in animals stimulates business demand.
APAC to account as Fastest Growing Region
China, India, Japan, South Korea, Australia and the rest of Asia-Pacific are expected to see development in the Veterinary Pain Relief Industry in Asia-Pacific. These countries have a significant population of cattle, as well as an increasing pet adoption pattern. Due to the increasing pet population and key players expanding their footprint in this area, Asia-Pacific is projected to experience the highest market growth potential over the forecast period.
The demand for veterinary pain relief in the Middle East and Africa is split into two main regions, namely the Middle East and Africa. In this region, the Middle East will have a large market share over the evaluation timeframe due to the expansion of healthcare facilities, the rise in medical tourism and the steady growth in the number of treatments for animals.
Veterinary Pain Management Market Competitive Landscape
Boehringer Ingelheim (Germany)
Assisi Animal Health (US)
Eltech K-Laser (Italy)
Merck Animal Health (US)
Bayer AG (Germany)
Chanelle Pharma Group (Ireland)
Dechra Pharmaceuticals PLC (UK)
Norbrook Laboratories (UK)
Vetoquinol S.A. (France)
December 2020: The award-winning Canine Arthritis Management (CAM) team released a new online course aimed at dog professionals aimed at helping improve understanding of arthritis in dogs and management of the condition.
August 2020: Zoetis partnered with the WSAVA to support its global pain council (GPC) – a specialist group of global veterinarians with expertise in companion animal pain management. The GPC addressed global variations in animal pain assessment and management by offering education and advisory resources.
Veterinary Pain Management Market Report Overview
By Animal Type
By Distribution Channel
Veterinary Hospitals & Clinics
|Market Size||USD 4.5 Billion|
|Forecast Units||Value (USD Billion)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Product, Application, End User and Distribution Channel|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||Ceva (US), Boehringer Ingelheim (Germany), Assisi Animal Health (US), Eltech K-Laser (Italy), Zoetis (US), Elanco (US), Merck Animal Health (US), Bayer AG (Germany), Chanelle Pharma Group (Ireland), Dechra Pharmaceuticals PLC (UK), Norbrook Laboratories (UK), Vetoquinol S.A. (France)|
|Key Market Opportunities||Growing Exploration of Untapped Markets to Create Growth Avenues for the Key Players|
|Key Market Drivers||Growing Animal Welfare Funding to Drive Market Growth|
Lack of awareness regarding procedures can hamper market growth.
The end users are research institutes & universities, veterinary hospitals & clinics, and laboratories.
The North American market has the upper hand in the market.
The Asia Pacific market would be the fastest growing.
The players are Zoetis, Boehringer Ingelheim, Ceva Santé Animale, Chanelle, Elanco, Dechra Pharmaceuticals, Vetoquinol, Norbrook Laboratories, Merck Animal Health, Bayer, and Assisi Animal Health.